Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement

Por Zhou, Jianya, Zheng, Jing, Zhao, Jing, Sheng, Yihong, Ding, Wei, Zhou, Jianying
Publicado no Thorac Cancer (2015)

Advanced lung adenocarcinomas with ROS1-rearrangement frequently show hepatoid cell

Por Zhao, Jing, Zheng, Jing, Kong, Mei, Zhou, Jianya, Ding, Wei, Zhou, Jianying
Publicado no Oncotarget (2016)

Different histopathology but the same clonality: ALK rearrangement in a patient with metastatic non-small-cell lung cancer

Por Zhao, Jing, Zhou, Jianya, Chen, Zhen, Wang, Bo, Zhang, Xiuming, Zhou, Jianying, Ding, Wei
Publicado no Int J Clin Exp Pathol (2015)

A Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features

Por Zhou, Jianya, Zhao, Jing, Zheng, Jing, Kong, Mei, Sun, Ke, Wang, Bo, Chen, Xi, Ding, Wei, Zhou, Jianying
Publicado no PLoS One (2016)

PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed

Por Zhang, Pei, Bao, Zhang, Xu, Liming, Zhou, Jianya, Lu, Guohua, Yao, Yinan, Liu, Rong, Gao, Qiqi, Shen, Yihong, Zhou, Jianying
Publicado no Oncotarget (2017)

Simultaneous quantitative determination of 5-aza-2′-deoxycytidine genomic incorporation and DNA demethylation by liquid chromatography tandem mass spectrometry as exposure-response...

Por Anders, Nicole M., Liu, Jianyong, Wanjiku, Teresia, Giovinazzo, Hugh, Zhou, Jianya, Vaghasia, Ajay, Nelson, William G., Yegnasubramanian, Srinivasan, Rudek, Michelle A.
Publicado no J Chromatogr B Analyt Technol Biomed Life Sci (2016)

Accurate and Economical Detection of ALK Positive Lung Adenocarcinoma with Semiquantitative Immunohistochemical Screening

Por Zhou, Jianya, Zhao, Jing, Sun, Ke, Wang, Bo, Wang, Lijun, Chen, Xi, Zheng, Jing, You, Qihan, Wang, Xiaoling, Ding, Wei, Zhou, Jianying
Publicado em 2014